NRAS and cancer: Although “senescence surveillance” pathways [55] (Table 1), involving p53 and N-Ras, directed to remove cancer cells are activated, other mechanisms intrinsic to the cancer cells together with microenvironmental factors may be related to immune system dysfunction.